Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-24-000161
Filing Date
2024-01-09
Accepted
2024-01-09 17:31:41
Documents
1
Period of Report
2024-01-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5687
  Complete submission text file 0001683168-24-000161.txt   7187
Mailing Address 1165 WRACK ROAD MEADOWBROOK PA 19046
Business Address
Salkind Gene (Reporting) CIK: 0001592481 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39669 | Film No.: 24524242

Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Issuer) CIK: 0001759186 (see all company filings)

EIN.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)